Close Menu

NEW YORK – CareDx reported on Monday that its preliminary revenues for the fourth quarter of 2019 are expected to be $35.7 million to $36.0 million, an increase of 52 percent to 53 percent compared to the $23.5 million in revenues reported in Q4 2018. Analysts expect the company to report $34.2 million in revenues for Q4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.